UBS AM Portfolio holdings
UBS AM is the US asset manager of UBS and grew out of Brinson Partners, an investment firm founded by Gary Brinson and made independent in 1989. Swiss Bank Corporation bought Brinson Partners in 1994, and once the bank merged with UBS, its founder Gary Brinson, who had run Swiss Bank's asset management business, became chief investment officer of UBS Asset Management. In 2024 the business took in Credit Suisse Asset Management and two of its own units, UBS Hedge Fund Solutions and UBS O’Connor, though the O’Connor business was later sold. Its clients are mainly institutions such as retirement plans, government bodies, endowments and foundations.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Equinix
EQIX
|
+$1.32B |
| 2 |
Digital Realty Trust
DLR
|
+$931M |
| 3 |
Western Digital
WDC
|
+$895M |
| 4 |
Simon Property Group
SPG
|
+$736M |
| 5 |
Realty Income
O
|
+$643M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$1.73B |
| 2 |
Eaton
ETN
|
+$1.21B |
| 3 |
Seagate
STX
|
+$1.1B |
| 4 |
Trane Technologies
TT
|
+$1.02B |
| 5 |
Accenture
ACN
|
+$1.01B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 40.05% |
| 2 | Financials | 11.12% |
| 3 | Healthcare | 9.54% |
| 4 | Consumer Discretionary | 9.08% |
| 5 | Communication Services | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2576
Wealthfront Corp
WLTH
$1.64B
| $370K | ﹤0.01% |
+41,411
| New | +$431K |
2026 Q2
0 quarters
|
|
2577
FTAI Aviation
FTAI
$16.4B
| $355K | ﹤0.01% |
1,314
-363,991
| -100% | -$91.6M |
2023 Q1
13 quarters
|
|
2578
iShares MSCI Intl Quality Factor ETF
IQLT
$13.7B
| $354K | ﹤0.01% |
7,146
-2,105
| -23% | -$103K |
2025 Q4
2 quarters
|
|
2579
The Magnum Ice Cream Company N.V.
MICC
$12.1B
| $349K | ﹤0.01% |
20,060
-5
| -0% | -$78 |
2025 Q4
2 quarters
|
|
2580
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.2B
| $347K | ﹤0.01% |
300
| – | – |
2026 Q1
1 quarter
|
|
2581
iShares US Healthcare Providers ETF
IHF
$1.46B
| $342K | ﹤0.01% |
6,186
| – | – |
2026 Q1
1 quarter
|
|
2582
Gildan
GIL
$6.37B
| $338K | ﹤0.01% |
6,555
| – | – |
2025 Q4
2 quarters
|
|
2583
Hallador Energy
HNRG
$430M
| $338K | ﹤0.01% |
19,444
| – | – |
2025 Q4
2 quarters
|
|
2584
Xtrackers MSCI Europe Hedged Equity ETF
DBEU
$790M
| $336K | ﹤0.01% |
6,229
-379
| -6% | -$19.5K |
2025 Q4
2 quarters
|
|
2585
VanEck Biotech ETF
BBH
$515M
| $335K | ﹤0.01% |
1,650
-66
| -4% | -$12.4K |
2025 Q4
2 quarters
|
|
2586
iShares Russell 3000 ETF
IWV
$19.7B
| $331K | ﹤0.01% |
777
| – | – |
2025 Q4
2 quarters
|
|
2587
iShares Select U.S. REIT ETF
ICF
$2.02B
| $327K | ﹤0.01% |
4,834
-885
| -15% | -$59.5K |
2026 Q1
1 quarter
|
|
2588
FinVolution Group
FINV
$680M
| $326K | ﹤0.01% |
+68,144
| New | +$337K |
2026 Q2
0 quarters
|
|
2589
iShares Dow Jones US ETF
IYY
$2.88B
| $326K | ﹤0.01% |
1,787
| – | – |
2026 Q1
1 quarter
|
|
2590
Canadian Imperial Bank of Commerce
CM
$106B
| $326K | ﹤0.01% |
2,832
| – | – |
2024 Q2
8 quarters
|
|
2591
Noah Holdings
NOAH
$474M
| $325K | ﹤0.01% |
32,570
| – | – |
2025 Q2
4 quarters
|
|
2592
Corsair Gaming
CRSR
$1.38B
| $325K | ﹤0.01% |
33,647
-37,637
| -53% | -$291K |
2022 Q1
17 quarters
|
|
2593
Del Monte Corp
DMC
$1.32B
| $324K | ﹤0.01% |
11,597
-88,111
| -88% | -$3.1M |
2013 Q2
52 quarters
|
|
2594
Bank of Montreal
BMO
$120B
| $323K | ﹤0.01% |
1,828
| – | – |
2024 Q2
8 quarters
|
|
2595
Wheaton Precious Metals
WPM
$60B
| $319K | ﹤0.01% |
2,841
| – | – |
2025 Q4
2 quarters
|
|
2596
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.37B
| $319K | ﹤0.01% |
7,240
-97,526
| -93% | -$4.29M |
2025 Q4
2 quarters
|
|
2597
Sable Offshore Corp
SOC
$355M
| $319K | ﹤0.01% |
103,440
-21,922
| -17% | -$279K |
2024 Q2
8 quarters
|
|
2598
Rentokil
RTO
$12.1B
| $317K | ﹤0.01% |
11,088
| – | – |
2025 Q4
2 quarters
|
|
2599
Prime Medicine
PRME
$798M
| $315K | ﹤0.01% |
85,300
| – | – |
2025 Q4
2 quarters
|
|
2600
RxSight
RXST
$189M
| $311K | ﹤0.01% |
64,510
| – | – |
2023 Q3
11 quarters
|
|
Similar funds
UBS AM's Q2 2026 Portfolio in Review
As of Q2 2026, UBS AM held 3,886 positions worth $550B, up 14% from $481B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
UBS AM's Q2 2026 filing shows 45 new, 996 increased, 1,636 reduced and 163 closed positions. Its largest new stake was Honeywell Aerospace: 1,676,062 shares worth $371M. The largest sale was Linde, an estimated $1.73B.
By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 35% a quarter earlier, followed by Financials and Healthcare.
- UBS AM's largest Q2 2026 buy was Honeywell Aerospace: 1,676,062 shares worth $371M.
- UBS AM added most to Equinix in Q2 2026, an estimated $1.32B increase.
- UBS AM's biggest Q2 2026 reduction was Linde, cutting an estimated $1.73B.
- UBS AM fully exited Hologic in Q2 2026, selling an estimated $174M.
- UBS AM's ten largest holdings make up 33% of its $550B portfolio in Q2 2026.
- UBS AM opened 45 new positions and closed 163 in Q2 2026.
- UBS AM's portfolio value rose 14% quarter-over-quarter to $550B.
Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.